Pharmaceutical Business review

Fougera granted approval to market generic scalp solution

Fougera’s Calcipotriene Topical Solution (scalp solution) is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp. It is available in a 60ml bottle.

David Klaum, senior vice president, commercial business operations, Fougera, said: “Fougera has received more FDA approvals for topical products during the past seven years than any other generic company.”